Custom Antibody Market (By Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies; By Service; By Source; By Application; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Custom Antibody Market 

5.1. COVID-19 Landscape: Custom Antibody Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Custom Antibody Market, By Type

8.1. Custom Antibody Market, by Type, 2022-2030

8.1.1. Monoclonal Antibodies

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Polyclonal Antibodies

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Recombinant Antibodies

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Custom Antibody Market, By Service

9.1. Custom Antibody Market, by Service, 2022-2030

9.1.1. Antibody Development

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Antibody Production & Purification

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Antibody Fragmentation & Labeling

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Custom Antibody Market, By Source 

10.1. Custom Antibody Market, by Source, 2022-2030

10.1.1. Rabbit

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Mice

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Custom Antibody Market, By Application

11.1. Custom Antibody Market, by Application, 2022-2030

11.1.1. Oncology

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Infectious Disease

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Immunology

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Neurobiology

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Stem Cells

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Cardiovascular Disease

11.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Custom Antibody Market, By End user

12.1. Custom Antibody Market, by End user, 2022-2030

12.1.1. Pharmaceutical and Biotechnology Companies

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Hospitals and Clinics

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Contract Research Organizations

12.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Custom Antibody Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Service (2017-2030)

13.1.3. Market Revenue and Forecast, by Source (2017-2030)

13.1.4. Market Revenue and Forecast, by Application (2017-2030)

13.1.5. Market Revenue and Forecast, by End user (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Service (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Source (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.1.7. Market Revenue and Forecast, by End user (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Service (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Source (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.1.8.5. Market Revenue and Forecast, by End user (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Service (2017-2030)

13.2.3. Market Revenue and Forecast, by Source (2017-2030)

13.2.4. Market Revenue and Forecast, by Application (2017-2030) 

13.2.5. Market Revenue and Forecast, by End user (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Service (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Source (2017-2030)

13.2.7. Market Revenue and Forecast, by Application (2017-2030) 

13.2.8. Market Revenue and Forecast, by End user (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Service (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Source (2017-2030)

13.2.10. Market Revenue and Forecast, by Application (2017-2030)

13.2.11. Market Revenue and Forecast, by End user (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Service (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Source (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Application (2017-2030)

13.2.13. Market Revenue and Forecast, by End user (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Service (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Source (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Application (2017-2030)

13.2.15. Market Revenue and Forecast, by End user (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Service (2017-2030)

13.3.3. Market Revenue and Forecast, by Source (2017-2030)

13.3.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.5. Market Revenue and Forecast, by End user (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Service (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Source (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.7. Market Revenue and Forecast, by End user (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Service (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Source (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.9. Market Revenue and Forecast, by End user (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Service (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Source (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End user (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Service (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Source (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End user (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Service (2017-2030)

13.4.3. Market Revenue and Forecast, by Source (2017-2030)

13.4.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.5. Market Revenue and Forecast, by End user (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Service (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Source (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.7. Market Revenue and Forecast, by End user (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Service (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Source (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.9. Market Revenue and Forecast, by End user (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Service (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Source (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End user (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Service (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Source (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End user (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Service (2017-2030)

13.5.3. Market Revenue and Forecast, by Source (2017-2030)

13.5.4. Market Revenue and Forecast, by Application (2017-2030)

13.5.5. Market Revenue and Forecast, by End user (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Service (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Source (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.5.7. Market Revenue and Forecast, by End user (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Service (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Source (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End user (2017-2030)

Chapter 14. Company Profiles

14.1. Thermo Fisher Scientific Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Merck KGaA

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Cell Signaling Technology Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Rockland Immunochemicals

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. BioLegend

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. GenScript

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Bio-Rad Laboratories Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Abcam PLC

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Agilent Technologies

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Innovagen Ab

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms